Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer

被引：8

作者：

Katerin Rojas, L. ^{[1
]}

Trilla-Fuertesr, Lucia ^{[2
]}

Gamez-Pozo, Angelo ^{[2
,3
]}

Chiva, Cristina ^{[4
,5
]}

Sepulveda, Juan ^{[1
]}

Manso, Luis ^{[1
]}

Prado-Vazquez, Guillermo ^{[2
,3
]}

Zapater-Moros, Andrea ^{[2
,3
]}

Lopez-Vacas, Rocio ^{[3
]}

Ferrer-Gomez, Maria ^{[3
]}

Mendiola, Cesar ^{[1
]}

Espinosa, Enrique ^{[6
,7
]}

Sabido, Eduard ^{[4
,5
]}

Ciruelos, Eva ^{[1
]}

Fresno Vara, Juan Angel ^{[2
,3
,7
]}

机构：

[1] Hosp Univ 12 Octubre, Dept Med Oncol, Madrid 28041, Spain

[2] Biomed Mol Med SL, Madrid 28049, Spain

[3] Hosp Univ La Paz IdiPAZ, Inst Genet Med & Mol INGEMM, Mol Oncol & Pathol Lab, Madrid 28029, Spain

[4] Barcelona Inst Sci & Technol, Ctr Genom Regulat, Prote Unit, Barcelona 08036, Spain

[5] Univ Pompeu Fabra, Prote Unit, Barcelona 08002, Spain

[6] Hosp Univ La Paz IdiPAZ, Med Oncol Serv, Madrid 28029, Spain

[7] Inst Salud Carlos III, CIBERONC, Madrid 28029, Spain

来源：

ECANCERMEDICALSCIENCE | 2019年 / 13卷

关键词：

breast cancer; triple negative; proteomics; central nervous system metastases; biomarkers; personalised medicine; PROTEIN; THROMBOSPONDIN-1; IDENTIFICATION; EXPRESSION; SIGNATURE; SHOTGUN; MARKER; ISG15;

D O I：

10.3332/ecancer.2019.891

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Breast cancer (BC) is the most frequent tumour in women. Triple negative tumours (TNBC)-which are associated with minor survival rates-lack markers predictive of response to anticancer drugs. Triple negative tumours frequently metastasise to the central nervous system (CNS). Objective: The main objective of this study was to study differences in tumour protein expression between patients with CNS metastases and those without this kind of spread, and propose new biomarkers. Methods: A retrospective study was performed. Targeted proteomics and statistical analyses were used to identify possible biomarkers. Results: Proteins were quantified by a targeted proteomics approach and protein expression data were successfully obtained from 51 triple negative formalin-fixed paraffin-embedded samples. ISG15, THBS1 and AP1M1 were identified as possible biomarkers related with CNS metastasis development. Conclusions: Three possible biomarkers associated with CNS metastases in TNBC tumours were identified: ISG15, THBS1 and AP1M1. They may become markers predicting the appearance of CNS infiltration in triple negative BC.

引用

页数：9

共 31 条

[1] The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer [J].

Bektas, Nuran ;

Noetzel, Erik ;

Veeck, Juergen ;

Press, Michael F. ;

Kristiansen, Glen ;

Naami, Amjad ;

Hartmann, Arndt ;

Dimmler, Arno ;

Beckmann, Matthias W. ;

Knuechel, Ruth ;

Fasching, Peter A. ;

Dahl, Edgar .

BREAST CANCER RESEARCH, 2008, 10 (04)

[2] Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors [J].

Bernhardt, Stephan ;

Bayerlova, Michaela ;

Vetter, Martina ;

Wachter, Astrid ;

Mitra, Devina ;

Hanf, Volker ;

Lantzsch, Tilmann ;

Uleer, Christoph ;

Peschel, Susanne ;

John, Jutta ;

Buchmann, Joerg ;

Weigert, Edith ;

Buerrig, Karl-Friedrich ;

Thomssen, Christoph ;

Korf, Ulrike ;

Beissbarth, Tim ;

Wiemann, Stefan ;

Kantelhardt, Eva Johanna .

BREAST CANCER RESEARCH, 2017, 19

[3] Genes that mediate breast cancer metastasis to the brain [J].

Bos, Paula D. ;

Zhang, Xiang H. -F. ;

Nadal, Cristina ;

Shu, Weiping ;

Gomis, Roger R. ;

Nguyen, Don X. ;

Minn, Andy J. ;

van de Vijver, Marc J. ;

Gerald, William L. ;

Foekens, John A. ;

Massague, Joan .

NATURE, 2009, 459 (7249) :1005-U137

[4] Prediction of Recurrence and Survival for Triple-Negative Breast Cancer (TNBC) by a Protein Signature in Tissue Samples [J].

Campone, Mario ;

Valo, Isabelle ;

Jezequel, Pascal ;

Moreau, Marie ;

Boissard, Alice ;

Campion, Loic ;

Loussouarn, Delphine ;

Verriele, Veronique ;

Coqueret, Olivier ;

Guette, Catherine .

MOLECULAR & CELLULAR PROTEOMICS, 2015, 14 (11) :2936-2946

[5] The cell biology of thrombospondin-1 [J].

Chen, H ;

Herndon, ME ;

Lawler, J .

MATRIX BIOLOGY, 2000, 19 (07) :597-614

[6] CYLD Inhibits Tumorigenesis and Metastasis by Blocking JNK/AP1 Signaling at Multiple Levels [J].

de Marval, Paula Miliani ;

Lutfeali, Shazia ;

Jin, Jane Y. ;

Leshin, Benjamin ;

Selim, M. Angelica ;

Zhang, Jennifer Y. .

CANCER PREVENTION RESEARCH, 2011, 4 (06) :851-859

[7] Elevated expression of IS615 in tumor cells interferes with the ubiquitin/26S proteasome pathway [J].

Desai, SD ;

Haas, AL ;

Wood, LM ;

Tsai, YC ;

Pestka, S ;

Rubin, EH ;

Saleem, A ;

Nur-E-Kamal, A ;

Liu, LF .

CANCER RESEARCH, 2006, 66 (02) :921-928

[8] ISG15: A double edged sword in cancer [J].

Desai, Shyamal D. .

ONCOIMMUNOLOGY, 2015, 4 (12)

[9] ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells [J].

Desai, Shyamal D. ;

Reed, Ryan E. ;

Burks, Julian ;

Wood, Laurence M. ;

Pullikuth, Ashok K. ;

Haas, Arthur L. ;

Liu, Leroy F. ;

Breslin, Jerome W. ;

Meiners, Sally ;

Sankar, Surendran .

EXPERIMENTAL BIOLOGY AND MEDICINE, 2012, 237 (01) :38-49

[10] Large-Scale Targeted Proteomics Using Internal Standard Triggered-Parallel Reaction Monitoring (IS-PRM) [J].

Gallien, Sebastien ;

Kim, Sang Yoon ;

Domon, Bruno .

MOLECULAR & CELLULAR PROTEOMICS, 2015, 14 (06) :1630-1644

← 1 2 3 4 →